Board to approve September quarter and half-year financial results

Revenue growth above 20%EBITDA margin compressionExceptional itemResults View source PDF Explain this filing

ASTRAZEN · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+0.8%Reaction day

₹6290.00

prior close

₹6350.00

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-2.5%+3.3% vs market

Pharmaceuticals peers, median of 173sector-0.8%+1.6% vs sector

On the reaction day the stock moved 3.3 pts more than Nifty Microcap 250 and 1.6 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.1

10m

+0.3

15m

+0.2

30m

+0.2

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+0.8-2.5+3.3-0.8+1.6

Next day

-0.3-1.1+0.8-0.8+0.5

+0.9-0.8+1.8-0.5+1.5

+1.3+1.3-0.1+0.3+1.0

-0.0+2.5-2.5+1.4-1.4

+2.1pendingpending+1.3+0.8

—————

15d

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 173Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

The Board will meet on November 5, 2026 to approve unaudited financial results for the quarter and six months ended September 30, 2026. The trading window for company insiders remains closed through November 7.

Likely market impact

No earnings figures or guidance were provided, so the likely price impact cannot be assessed until the results are published.

By the numbersStandalone · Q2 FY27 vs Q2 FY26

	Q2 FY27	Q2 FY26	Change
Revenue	₹729.1 Cr	₹559.1 Cr	+30.4%
Operating profit	₹88.33 Cr	₹71.94 Cr	+22.8%
Profit after tax	₹62.33 Cr	₹54.22 Cr	+15.0%
EBITDA margin	11.1%	12.5%	−1.4 pp

From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.